Sort
21,281 grants matching “influenza”
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy
$483,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2019 · AI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy
$483,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2022 · AI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy
$483,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2021 · AI
Systems investigation of vaccine responses in B cell depleted autoimmune patients
$483,750David A. Hafler · Yale University · U19 · FY2023 · AI
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy
$483,750Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2020 · AI
INFLUENZA SELF-ADMINISTRATION VACCINE SYSTEM
$483,743Innoject, Inc. · R43 · FY2004 · AI
Prenatal Factors and Risk of Bipolar Disorder
$483,709Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2006 · MH
A three-population three-scale social network model to assess disease dispersion
$483,684Ling Bian · State University Of New York At Buffalo · R01 · FY2017 · GM
Host response to post-operative pneumonia
$483,585State University Of New York At Buffalo · R01 · FY2003 · AI
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma
$483,551Hong W Chu · National Jewish Health · R01 · FY2019 · HL
Testing Novel Interventions to Protect Workers from Airborne Infections
$483,308Edward A. Nardell · Brigham And Women'S Hospital · R01 · FY2014 · OH
Molecular Analysis of Pathogens in Otitis Media by PCR
$483,276Garth D. Ehrlich · Allegheny-Singer Research Institute · R01 · FY2007 · DC
Combinations of FDA-Approved Host-Targeted Drugs with Broad Antiviral Activity
$483,247Jack Thanh Nguyen · Adamas Pharmaceuticals, Inc. · R33 · FY2015 · AI
Molecular Analysis of Pathogens in Otitis Media by PCR
$483,216Garth D. Ehrlich · Allegheny-Singer Research Institute · R01 · FY2006 · DC
Standing Orders to Improve HPV Vaccination
$483,215Cynthia M Rand · University Of Rochester · R01 · FY2023 · CA
Task A54: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential
$483,208Bart Tarbet · Utah State University · N01 · FY2021 · AI
DCM/Integrin TFH Positioning Cues for Support of the Germinal Center Response
$483,124Deborah J Fowell · Cornell University · R01 · FY2021 · AI
Development of Diagnostic Microarray for Influenza A
$483,067University Of Colorado At Boulder · U01 · FY2005 · AI
EBV and Heterologous Alloimmunity in Humanized Mice
$483,023Liisa K Selin · Univ Of Massachusetts Med Sch Worcester · P01 · FY2014 · AI
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$483,001Henry C Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Treating T cell immunodeficiency among older adults by a recombinant Foxn1 fusion protein
$483,000Laijun Lai · University Of Connecticut Storrs · R33 · FY2024 · AG
Treating T cell immunodeficiency among older adults by a recombinant Foxn1 fusion protein
$483,000Laijun Lai · University Of Connecticut Storrs · R33 · FY2023 · AG
Understanding the OAS/RNase L pathway during pathogenic viral infections
$483,000James M Burke · University Of Florida · R35 · FY2025 · GM
Understanding the OAS/RNase L pathway during pathogenic viral infections
$483,000James M Burke · University Of Florida · R35 · FY2023 · GM
Understanding the OAS/RNase L pathway during pathogenic viral infections
$483,000James M Burke · University Of Florida · R35 · FY2024 · GM